LakeShore Biopharma Co Ltd (LSB)
0.8373
+0.06
(+7.59%)
USD |
NASDAQ |
Sep 27, 16:00
0.862
+0.02
(+2.95%)
After-Hours: 20:00
LakeShore Biopharma Cash from Operations (Quarterly): -20.15M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -20.15M |
Date | Value |
---|---|
September 30, 2022 | -15.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.15M
Minimum
Sep 2023
-15.68M
Maximum
Sep 2022
-17.92M
Average
-17.92M
Median
Cash from Operations (Quarterly) Benchmarks
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | -- |
Zai Lab Ltd | -42.17M |
China SXT Pharmaceuticals Inc | -- |
Adagene Inc | -- |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -3.237M |
Cash from Financing (Quarterly) | 6.199M |